Sign inGet started

MOATAZEDI DAVID

Insider CIK 1700836 · OBLN Director · EOLS See Remarks, Director · BMRA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
EOLS Evolus, Inc. S Sale2026-09-022026-09-04105,108$9.04 $950.2K499,592SEC↗
EOLS Evolus, Inc. S Sale2026-09-022026-09-04105,108$9.04 $950.0K499,592SEC↗
BMRA BIOMERICA INC P Buy2026-08-262026-08-2710,000$1.60 $16.0K40,625SEC↗
BMRA BIOMERICA INC P Buy2026-08-262026-08-2710,000$1.60 $16.0K40,625SEC↗
EOLS Evolus, Inc. S Sale2026-03-202026-03-2013,669$4.75 $64.9K604,700SEC↗
EOLS Evolus, Inc. S Sale2026-03-172026-03-18116,720$4.89 $570.8K618,369SEC↗
EOLS Evolus, Inc. M Exercise deriv2026-03-162026-03-1867,489— $067,488SEC↗
EOLS Evolus, Inc. M Exercise2026-03-162026-03-1867,489— $0735,089SEC↗
EOLS Evolus, Inc. A Award deriv2026-02-172026-02-19457,541— $0457,541SEC↗
EOLS Evolus, Inc. A Award deriv2026-02-172026-02-19626,424— $0626,424SEC↗
EOLS Evolus, Inc. A Award2026-02-172026-02-19313,212— $0667,600SEC↗
EOLS Evolus, Inc. S Sale2025-12-222025-12-2910,539$7.15 $75.4K354,388SEC↗
BMRA BIOMERICA INC A Award2025-12-122025-12-3120,000— $030,625SEC↗
EOLS Evolus, Inc. S Sale2025-06-162025-06-1616,582$9.89 $164.0K364,927SEC↗
EOLS Evolus, Inc. S Sale2025-06-132025-06-16111,323$10.05 $1.12M381,509SEC↗
EOLS Evolus, Inc. S Sale2025-05-122025-05-1415,787$9.87 $155.8K492,832SEC↗
EOLS Evolus, Inc. S Sale2025-03-272025-03-286,251$12.40 $77.5K508,619SEC↗
EOLS Evolus, Inc. S Sale2025-03-182025-03-20103,376$13.26 $1.37M514,870SEC↗
EOLS Evolus, Inc. A Award deriv2025-03-072025-03-11190,799— $0190,799SEC↗
EOLS Evolus, Inc. A Award deriv2025-03-072025-03-11135,925— $0135,925SEC↗
EOLS Evolus, Inc. A Award2025-03-072025-03-1195,399— $0618,246SEC↗
EOLS Evolus, Inc. S Sale2024-12-232024-12-2610,502$10.85 $113.9K522,847SEC↗
BMRA BIOMERICA INC A Award2024-12-132024-12-1785,000$0.31 $26.4K85,000SEC↗
EOLS Evolus, Inc. M Exercise deriv2024-06-062024-06-06175,940— $01,006,079SEC↗
EOLS Evolus, Inc. S Sale2024-06-062024-06-06175,940$12.59 $2.22M533,349SEC↗
EOLS Evolus, Inc. M Exercise2024-06-062024-06-06175,940$7.28 $1.28M709,289SEC↗
EOLS Evolus, Inc. M Exercise deriv2024-06-052024-06-06155,278— $0155,281SEC↗
EOLS Evolus, Inc. M Exercise2024-06-052024-06-06155,278$5.46 $847.8K688,627SEC↗
EOLS Evolus, Inc. S Sale2024-06-052024-06-06155,278$12.92 $2.01M533,349SEC↗
EOLS Evolus, Inc. S Sale2024-06-042024-06-06140,214$12.73 $1.78M533,349SEC↗
EOLS Evolus, Inc. S Sale2024-05-102024-05-1416,051$12.72 $204.2K673,563SEC↗
EOLS Evolus, Inc. S Sale2024-03-272024-03-296,236$13.86 $86.4K689,614SEC↗
EOLS Evolus, Inc. S Sale2024-03-192024-03-2196,566$13.92 $1.34M695,850SEC↗
EOLS Evolus, Inc. S Sale2024-02-222024-02-237,706$13.08 $100.8K792,416SEC↗
EOLS Evolus, Inc. A Award2024-02-212024-02-2361,202— $0800,122SEC↗
EOLS Evolus, Inc. A Award deriv2024-02-072024-02-09181,460— $0181,460SEC↗
EOLS Evolus, Inc. A Award deriv2024-02-072024-02-09134,977— $0134,977SEC↗
EOLS Evolus, Inc. A Award2024-02-072024-02-09134,976— $0738,920SEC↗
BMRA BIOMERICA INC A Award deriv2023-12-132023-12-1475,000— $075,000SEC↗
EOLS Evolus, Inc. S Sale2023-12-082023-12-0831,300$9.73 $304.5K603,944SEC↗
EOLS Evolus, Inc. S Sale2023-12-062023-12-0851,348$10.09 $518.1K635,244SEC↗
EOLS Evolus, Inc. S Sale2023-08-162023-08-1614,778$10.27 $151.8K686,592SEC↗
EOLS Evolus, Inc. A Award2023-08-142023-08-1691,803— $0701,370SEC↗
EOLS Evolus, Inc. A Award deriv2023-05-082023-05-09560,000— $0560,000SEC↗
BMRA BIOMERICA INC A Award deriv2023-04-202023-12-1125,000— $025,000SEC↗
BMRA BIOMERICA INC A Award deriv2023-04-202023-12-1132,000— $032,000SEC↗
EOLS Evolus, Inc. S Sale2023-03-272023-03-296,110$8.47 $51.8K609,567SEC↗
EOLS Evolus, Inc. S Sale2023-03-142023-03-1664,211$8.47 $543.9K615,677SEC↗
EOLS Evolus, Inc. A Award deriv2023-01-252023-01-27257,009— $0257,009SEC↗
EOLS Evolus, Inc. A Award2023-01-252023-01-27187,927— $0679,888SEC↗
EOLS Evolus, Inc. S Sale2022-05-162022-05-1855,321$13.64 $754.6K491,961SEC↗
EOLS Evolus, Inc. S Sale2022-03-282022-03-306,104$11.62 $70.9K547,282SEC↗
EOLS Evolus, Inc. S Sale2022-03-082022-03-1037,972$9.73 $369.5K553,386SEC↗
EOLS Evolus, Inc. A Award deriv2022-01-242022-01-26310,559— $0310,559SEC↗
EOLS Evolus, Inc. A Award2022-01-242022-01-26214,286— $0591,358SEC↗
EOLS Evolus, Inc. S Sale2021-08-162021-08-1747,737$11.35 $541.8K377,072SEC↗
EOLS Evolus, Inc. S Sale2021-08-132021-08-1722,708$10.66 $242.1K424,809SEC↗
EOLS Evolus, Inc. S Sale2021-08-102021-08-1241,763$11.18 $466.9K531,043SEC↗
EOLS Evolus, Inc. S Sale2021-08-102021-08-1241,763$11.18 $466.9K447,517SEC↗
EOLS Evolus, Inc. A Award2021-03-262021-03-2648,853— $0489,280SEC↗
EOLS Evolus, Inc. A Award2021-01-272021-02-01266,667— $0440,427SEC↗
EOLS Evolus, Inc. S Sale2021-01-252021-01-268,310$7.46 $62.0K173,760SEC↗
EOLS Evolus, Inc. A Award2020-05-132020-05-15100,000— $0182,070SEC↗
EOLS Evolus, Inc. A Award deriv2020-01-232020-01-24141,910— $0141,910SEC↗
EOLS Evolus, Inc. A Award2020-01-232020-01-2482,070— $082,070SEC↗
OBLN OBALON THERAPEUTICS INC A Award2019-07-232019-07-2578,125— $083,619SEC↗
EOLS Evolus, Inc. A Award deriv2019-01-232019-01-25125,000— $0125,000SEC↗
OBLN OBALON THERAPEUTICS INC A Award2018-08-232018-08-275,494$1.82 $10.0K5,494SEC↗
OBLN OBALON THERAPEUTICS INC A Award deriv2018-06-132018-08-2981,774— $081,774SEC↗
OBLN OBALON THERAPEUTICS INC A Award deriv2018-06-132018-06-1481,774— $081,774SEC↗
EOLS Evolus, Inc. A Award deriv2018-05-062018-05-081,182,019$7.28 $8.61M1,182,019SEC↗
OBLN OBALON THERAPEUTICS INC A Award deriv2017-06-062017-06-1636,554— $036,554SEC↗
OBLN OBALON THERAPEUTICS INC A Award deriv2017-03-132017-03-1559,988— $059,988SEC↗